REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER

Trial Identifier: D9070R00001
Sponsor: AstraZeneca
Start Date: July 2024
Primary Completion Date: January 2025
Study Completion Date: January 2025
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Italy Bologna, Italy
Italy Catanzaro, Italy
Italy Lucca, Italy
Italy Napoli, Italy
Italy Palermo, Italy
Italy Pistoia, Italy
Italy Prato, Italy
Italy Roma, Italy
Italy Trento, Italy
Italy Varese, Italy
Italy Vimercate, Italy